Related Experiment Video
Updated: Jun 27, 2026

Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases
Published on: January 1, 2016
"Future" threat of gram-negative resistance in Singapore
1Department of Infectious Diseases, Singapore General Hospital, Singapore. tan.thuan.tong@sgh.com.sg
Abstract:
The emergence of multidrug-resistant gram-negative bacteria is challenging the treatment of serious nosocomial infections. This is an international trend that is mirrored in Singapore too. Reports of strains resistant to all currently available agents have surfaced here and possibly have taken root here as well. The direst situation is among the non-fermenters, Pseudomonas aeruginosa and Acinetobacter baumannii. This is followed closely by the Enterobacteriaceae family with their array of extended-spectrum beta-lactamases, AmpC beta-lactamases and carbapenemases. There are also resistance mechanisms such as efflux pumps and porins downregulation that effect resistance against multiple classes of agents. Potentiating these developments is the dwindling "pipeline" of new agents. Hence, there is a real concern that we are running out of options for our patients. Novel antibiotic combinations, enhanced infection control, antibiotic cycling, computer-assisted programmes, and maybe in the distant future, non-antimicrobial agents is all that we have.
Insights
Multidrug-resistant gram-negative bacteria, particularly Pseudomonas aeruginosa and Acinetobacter baumannii, pose a significant threat in Singapore. The limited pipeline of new antibiotics raises concerns about future treatment options for nosocomial infections.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Multidrug-resistant (MDR) gram-negative bacteria are a growing global concern for treating nosocomial infections.
- This international trend is evident in Singapore, with reports of strains resistant to all available antibiotics.
- Specific challenges include resistance in non-fermenters like Pseudomonas aeruginosa and Acinetobacter baumannii, and the Enterobacteriaceae family.
Purpose of the Study:
- To highlight the escalating threat of multidrug-resistant gram-negative bacteria in Singapore.
- To identify key bacterial groups and resistance mechanisms contributing to treatment challenges.
- To underscore the urgent need for novel therapeutic strategies and infection control measures.
Main Methods:
- Review of current literature and clinical reports on antimicrobial resistance patterns in Singapore.
- Identification of prevalent gram-negative bacterial pathogens and their resistance mechanisms (e.g., beta-lactamases, efflux pumps).
- Assessment of the existing and future pipeline of antimicrobial agents.
Main Results:
- Emergence and establishment of pan-resistant gram-negative bacteria in Singapore.
- High prevalence of resistance in Pseudomonas aeruginosa, Acinetobacter baumannii, and Enterobacteriaceae.
- Presence of various resistance mechanisms including extended-spectrum beta-lactamases, AmpC beta-lactamases, carbapenemases, efflux pumps, and porin downregulation.
- Dwindling pipeline of new antibiotic agents.
Conclusions:
- Singapore faces a critical challenge with multidrug-resistant gram-negative bacteria, mirroring international trends.
- The combination of resistant pathogens and a limited drug pipeline creates a dire clinical situation.
- Future strategies must include novel antibiotic combinations, enhanced infection control, and potentially non-antimicrobial approaches.
Related Concept Videos
Development of Antibiotic Resistance
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Stringent Response in E. coli
Gene Regulation in Microbial Communities: Quorum Sensing
Microbiota Modulation by Antibiotics
